|
|
Xingshen Sun, Ziying Yan, Yaling Yi, Ziyi Li, Diana Lei, Christopher S. Rogers, Juan Chen, Yulong Zhang, Michael J. Welsh, Gregory H. Leno, John F. Engelhardt
J Clin Invest. 2008;
118(4):1578
doi:10.1172/JCI34599
Abstract |
Full text
| PDF

S
omatic cell gene targeting combined with nuclear transfer cloning presents tremendous potential for the creation of new, large-animal models of human diseases. Mouse disease models often fail to reproduce human phenotypes, underscoring the need for the generation and study of alternative disease models. Mice deficient for CFTR have been poor models for cystic fibrosis (CF), lacking many aspects of human CF lung disease. In this study, we describe the production of a CFTR gene–deficient model in the domestic ferret using recombinant adeno-associated virus–mediated gene targeting in fibroblasts, followed by nuclear transfer cloning. As part of this approach, we developed a somatic cell rejuvenation protocol using serial nuclear transfer to produce live CFTR-deficient clones from senescent gene-targeted fibroblasts. We transferred 472 reconstructed embryos into 11 recipient jills and obtained 8 healthy male ferret clones heterozygous for a disruption in exon 10 of the CFTR gene. To our knowledge, this study represents the first description of genetically engineered ferrets and describes an approach that may be of substantial utility in modeling not only CF, but also other genetic diseases.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(28)
| Title and authors |
Publication |
Year |
Generation of SV40-transformed rabbit tracheal-epithelial-cell-derived blastocyst by somatic cell nuclear transfer
D. de Semir, R. Maurisse, F. Du, J. Xu, X. Yang, B. Illek, D. C. Gruenert
|
Cell Tissue Res
|
2012 |
Gene and cell therapy for cystic fibrosis: From bench to bedside
Massimo Conese, Fiorentina Ascenzioni, A. Christopher Boyd, Charles Coutelle, Ida De Fino, Stefaan De Smedt, Joanna Rejman, Joseph Rosenecker, Dirk Schindelhauer, Bob J. Scholte
|
Journal of Cystic Fibrosis
|
2011 |
Current Status and Future Directions of Gene and Cell Therapy for Cystic Fibrosis
Uta Griesenbach, Eric W.F.W. Alton
|
BioDrugs
|
2011 |
Mouse models of cystic fibrosis: Phenotypic analysis and research applications
Martina Wilke, Ruvalic M. Buijs-Offerman, Jamil Aarbiou, William H. Colledge, David N. Sheppard, Lhousseine Touqui, Alice Bot, Huub Jorna, Hugo R. De Jonge, Bob J. Scholte
|
Journal of Cystic Fibrosis
|
2011 |
Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease
Basma M Ibrahim, Michael D Tsifansky, Yan Yang, Yoon Yeo
|
Expert Opin. Drug Deliv.
|
2011 |
Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung
G McLachlan, H Davidson, E Holder, L A Davies, I A Pringle, S G Sumner-Jones, A Baker, P Tennant, C Gordon, C Vrettou, R Blundell, L Hyndman, B Stevenson, A Wilson, A Doherty, D J Shaw, R L Coles, H Painter, S H Cheng, R K Scheule, J C Davies, J A Innes, S C Hyde, U Griesenbach, E W F W Alton, A C Boyd, D J Porteous, D R Gill, D D S Collie
|
Gene Ther
|
2011 |
Genetic therapies for cystic fibrosis lung disease
P. L. Sinn, R. M. Anthony, P. B. McCray
|
Human Molecular Genetics
|
2011 |
Developing new products in cystic fibrosis: Needs and obstacles for activities of small and middle-sized companies
Miriam Schlangen, Andreas L.G. Reimann
|
Journal of Cystic Fibrosis
|
2011 |
AAV-mediated gene targeting methods for human cells
Iram F Khan, Roli K Hirata, David W Russell
|
Nat Protoc
|
2011 |
Sequential targeting of CFTR by BAC vectors generates a novel pig model of cystic fibrosis
N. Klymiuk, L. Mundhenk, K. Kraehe, A. Wuensch, S. Plog, D. Emrich, M. C. Langenmayer, M. Stehr, A. Holzinger, C. Kröner
|
J Mol Med
|
2011 |
|